Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Faculty who have authored publication Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors.

NameTitleDepartmentInstitution
Razelle Kurzrock MDCenter Associate Director, ProfessorMedicineMedical College of Wisconsin